The Importance of Understanding Clinical Trial Design as a Medtech CEO
Interview with Nadim Yared, CEO of CVRx
We recently caught up with Nadim Yared, the CEO of CVRx, a pioneer in neuromodulation for cardiovascular diseases.
Nadim has been CEO for 15 years and led CVRx through some major pivots and incredible successes. Today, we’re going to discuss his journey with the company, including Nadim’s expertise on clinical trial strategy, startup funding, and working with FDA & CMS.
But first, here’s a bit more about Nadim Yared and his background:
Nadim holds two graduate degrees, and started his career with GE. After getting his MBA at INSEAD, he went on to run several business units for GE, then spent four years as the head of Medtronic’s Surgical Navigation division. Nadim was then recruited to take the helm at CVRx in 2006, and has been CEO ever since.
You May Like These Articles
Medsider Premium
Become a premium member and unlock access to exclusive Medsider benefits.